Observed Cost and Variations in Short Term Cost‐Effectiveness of Therapy for Ischemic Stroke in Interventional Management of Stroke (IMS) III

Observed Cost and Variations in Short Term Cost‐Effectiveness of Therapy for Ischemic Stroke in Interventional Management of Stroke (IMS) III

BackgroundExamination of linked data on patient outcomes and cost of care may help identify areas where stroke care can be improved. We report on the association between variations in stroke severity, patient outcomes, cost, and treatment patterns observed over the acute hospital stay and through th...

Full description

Bibliographic Details
Main Authors: Kit N. Simpson, Annie N. Simpson, Patrick D. Mauldin, Yuko Y. Palesch, Sharon D. Yeatts, Dawn Kleindorfer, Thomas A. Tomsick, Lydia D. Foster, Andrew M. Demchuk, Pooja Khatri, Michael D. Hill, Edward C. Jauch, Tudor G. Jovin, Bernard Yan, Rüdiger von Kummer, Carlos A. Molina, Mayank Goyal, Wouter J. Schonewille, Mikael Mazighi, Stefan T. Engelter, Craig Anderson, Judith Spilker, Janice Carrozzella, Karla J. Ryckborst, L. Scott Janis, Joseph P. Broderick
Format: Article
Language:English
Published: Wiley 2017-05-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
cost
cost‐effectiveness
ischemic
stroke
stroke care
tissue‐type plasminogen activator
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.116.004513

Similar Items

Similar Items